Overview
Efferta Blends is a Polish manufacturer and supplier of dietary supplements operating since 1996. It provides contract manufacturing and private-label production of effervescent tablets, lozenges, hard capsules, powders, other solid forms and sweeteners, as well as packaging services. Manufacturing takes place in a facility and laboratory managed in accordance with ISO 22000, BRC and GMP standards.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 83 days early.
- 202528/05/2026
- 202414/05/2025
- 202313/05/2024
- 202219/04/2023
- 202118/05/2022
- 202019/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Contract manufacturing of dietary supplements
- Effervescent tablets
- Lozenges
- Hard capsules
- Powdered supplements
- Sweeteners
- Supplement packaging
- Formulation development
Website technology
- Website
- WordPress
- Elementor
Authorized Representatives
Manner of representation
To make declarations of will on behalf of the company, two members of the management board acting jointly are authorized.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Izabella Ewa Lewandowska Gołdaage 67 | 50 | $6,753.11 | 50% |
Hanna Małgorzata Pomianowskaage 72 | 18 | $2,431.12 | 18% |
Bartłomiej Pomianowskiage 50 | 16 | $2,160.99 | 16% |
Marek Wojciech Pomianowskiage 47 | 16 | $2,160.99 | 16% |
Hanna Małgorzata Pomianowska, Bartłomiej Pomianowski and Marek Wojciech Pomianowski hold a combined 50% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-12-28.
68 1020 1068 0000 1102 0531 3236- 30 1020 1068 0000 1302 0532 4589
- 58 1020 1068 0000 1102 0532 4571
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,378$5,378 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,242$6,242 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,524$5,524 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| INV Polandsp. z o.o. | $6,811,226.32 | invpoland.com | ||
| INV Poland sp. z o.o.sp. k. | $5,980,381.22 | invpoland.com | ||
| BGW Pharmasp. z o.o. | $5,726,873.65 | bgwpharma.com | ||
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | ||
| Biocorposp. z o.o. | $2,580,678.06 | biocorpo.pl | ||
| Amileksp. z o.o. | $1,792,976.38 | amilek.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Auralab360sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io |
Change history
| Date | Event | |
|---|---|---|
| 2015-09-30 | Switch to PKD 2007 (65 PKD 2004 codes → 10 PKD 2007 codes) | |
| 2006-12-19 | Entered in the register |
FAQ
Last updated: 2026-05-28